TNFSF10 and osteosarcoma: Further, the concurrent treatment of SFN and TRAIL in Saos2 and MG63 osteosarcoma cells effectively overcame TRAIL resistance by significantly enhancing apoptosis through the induction of Bid cleavage, activation of caspases, and upregulation of DR5 levels [65].